Drug Profile
Research programme: skin disorder therapeutics - Trophea
Latest Information Update: 03 Oct 2023
Price :
$50
*
At a glance
- Originator Trophea
- Class Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Skin disorders
Most Recent Events
- 03 Oct 2023 Discontinued - Preclinical for Skin disorders in Sweden (Topical) (Trophea website, October 2023)
- 28 Feb 2021 No recent reports of development identified for preclinical development in Skin-disorders in Sweden (Topical, Gel)
- 05 Oct 2018 The Danish Medicines Agency and the Ethics Committee approves IND application for fixed-dosed combination gel in Skin atrophy